Through their partnership, the companies intend to highlight how Theranos’ services can be used to lower the cost of care in areas where costs of medical diagnostic testing are high due to a lack of healthcare resources. Theranos’ tests are all at least 50 percent below the Medicare reimbursement rate.
Under the deal, all of Theranos’ tests will be available to Capital BlueCross members in Central Pennsylvania, including full fertility panels for $35 and simple cholesterol tests for $2.99.
“Our partnership with Capital BlueCross is centered on a common mission — to provide access to high-quality, affordable healthcare, so that people everywhere can own their health and take action to live their best lives,” said Theranos Founder and CEO Elizabeth Holmes.
More articles on Theranos:
What drives Theranos founder Elizabeth Holmes
Frost & Sullivan report lists top 10 companies disrupting healthcare
Cleveland Clinic and Theranos enter long-term strategic alliance
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
